Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Why medtech should keep its lobbying expectations low in 2017

August 29, 2017 By Chris Newmarker

Capitol Hill medtechPolitical chaos means fewer opportunities for the medtech industry to get much done in Congress this year, says Clayton Hall, VP of government affairs for the Medical Device Manufacturers Assn.

When it comes to permanent repeal of the 2.3% medical device excise tax that was part of the 2010 Affordable Care Act, there are fewer legislative opportunities, Hall said during a webinar hosted Aug. 23 by Medmarc Insurance Group.

“There are opportunities – fewer and fewer though to get full repeal. So the likeliest outcome right now is probably an additional suspension. But there are some opportunities to get full repeal. And that’s what we’re fighting for,” Hall said.

Mark Leahey, the MDMA’s president and CEO, said in a later statement: “We are confident that Congress will get the job done this year, and MDMA remains committed to working with policy makers to accomplish this bipartisan goal.”

Hall during the webinar listed a host of woes besetting President Donald Trump as he tries to get his agenda passed: the investigation into Russian interference in the 2016 presidential election, Trump’s controversial firing of FBI director James Comey, controversy over Trump not quickly condemning white supremacist protestors in Charlottesville, turnover among top Trump staffers, escalating tensions with Congress, and more.

Shaky relationships between Trump and some Republican senators are causing even more problems.

“These are real, serious, challenges to the president as he tries to move an agenda through the Senate,” Hall said.

Efforts to repeal and replace the Affordable Care Act appear dead for now as Congress moves on to tax reform – but that, too, could be a tough lift. Meanwhile, there are must-do actions that Congress must pass such as raising the debt ceiling and getting some kind of spending bill passed. (Trump in recent days threatened to let the government shut down if funding for a wall on the U.S.-Mexico border isn’t included.)

After the woes around ACA repeal-and-replace, Hall expects possible action on more discreet healthcare measures, including something to deal with the opioid abuse crisis and legislation related to “right-to-try,” lab-developed tests, cybersecurity and off-label promotion.

Said Hall” “I think what we’ll see when Congress gets back, they’ll spend much of September dealing with all these must-pass bills. And I think they will begin shifting in a very public way towards tax reform. … That’s gonna grow. They’re gonna go back in a more robust way, go back into their districts and across the base, sell something, put a package together. But again, I think the odds are long that they’re gonna be able to pass something this calendar year. The likeliest outcome is that they pass something the early part of next year.”

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

You may also like:

  • Donald Trump healthcare officials
    5 officials running healthcare under Trump
  • Donald Trump medtech tops stories
    Analysis: 5 ways Trump is making things uncertain for medtech

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Related Articles Read More >

A photo of an FDA employee in the FDA Life Sciences Laboratory I in Building 64, which houses the Center for Drug Evaluation and Research and the Center for Devices and Radiological Health.
Device developers must take action as experts leave FDA
This is the logo of MedTech Innovator.
MedTech Innovator announces 65 startups for its 2025 cohort
This is the logo of the U.S. Food and Drug Administration or FDA.
FDA rolls out ‘Elsa,’ a generative AI tool to boost efficiency across the agency
Proactive IP strategy to navigate your medtech startup through uncertain times
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe